Professor Sujoy Kumar Guha has spent nearly 50 years developing RISUG, the world’s only reversible male contraceptive drug. RISUG has potential to change birth control around the world: the one-time injection is minimally invasive, effective for up to 15 years and has negligible side effects.
Despite successful clinical trials on over 2,000 humans, Guha still faces challenges. He’s up against the international pharma lobby and the $30 billion contraceptive market. The 84-year-old biomedical engineer-turned-doctor is now guiding the RISUG project through the last bureaucratic hurdles – but will he realize his dream and obtain final approval and a licence to manufacture the drug for the global market before his time runs out?
Even after half a century of work, Guha refuses to give up.
Every night, he goes for a jog to clear his mind and work through the next set of problems.
Add to playlist